Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities

The list is based on reports received by H. Lundbeck A/S from the company's executives today or yesterday.

Name:	Per Wold-Olsen
Job position of the executive:	Chairman of Supervisory Board
Relation to executive (associated person or legal entity):
ID code (ISIN code):	DK 0010287234
Description of the security:	Share
Nature of the transaction:	Purchase of shares
Date of trading:	16 November 2007
Market on which the trading was effected:	Copenhagen Stock Exchange
Number of traded securities:	10,000	pcs.
Market price of securities traded:	1,472,500	DKK

Persons/entities under an obligation to report

Persons or entities under an obligation to report are defined as members of the Executive Management and the Supervisory Board of H. Lundbeck A/S and persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

spouse or cohabitant

children below the age of 18

legal entities in which the insider has a controlling influence

The content of this release will have no influence on the Lundbeck Group's financial result for 2007.

Lundbeck contacts

Investors:	Media:

Jacob Tolstrup	Anders Schroll
Director, Corporate Reporting	Head of Communication
+45 36 43 30 79	+45 36 43 20 81

________________________

Stock Exchange Release No 306 - 20 November 2007

About Lundbeck

H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. In 2006, the company's revenue was DKK 9.2 billion (approximately EUR 1.2 billion or USD 1.6 billion). The number of employees is approximately 5,300 globally. For further information, please visit www.lundbeck.com